Dr. Josh Bloom and Dr. Henry I. Miller in Forbes.com, January 14, 2015
The development of pharmaceuticals is among the riskiest of businesses. It now takes 10-15 years for a pharmaceutical company to get a new drug approved, and on average the cost exceeds $2.5 billion. To establish its safety and effectiveness, a candidate drug or vaccine undergoes a lengthy process of laboratory,...[Read more].
In Forbes, Dr. Josh Bloom, American Council on Science and Health Director of Chemical and Pharmaceutical Sciences, and Dr. Henry I. Miller of the Hoover Institute, note that the development of pharmaceuticals is among the riskiest of businesses and that it now takes 10-15 years for a pharmaceutical company to get a new drug approved, and on average the cost exceeds $2.5 billion. To establish its safety and effectiveness, a candidate drug or vaccine undergoes a lengthy process of laboratory,...[Read more].
